Lonnie Bookbinder, MBA, PhD
CEO, Board Chairman
Leadership in pharma industry, drug licensing to pharma, serial entrepreneur, 47 years in industry
Brad Niles, PhD
Chief Operating Officer, VP R&D, Board Member
Managed Oncology Labs at UCD/Industry, expert in drug discovery, in-vitro assays, and IP
Glenn Kazo
Chief Business Officer
Founder of Enzon, inventor of Pegylation technology. Had a leading role in 3 IPOs and raised over $500M.
Mark Kester, PhD
Scientific Advisor
Director of Nanotech Center & Pharmacology Professor at U. VA, Drug Delivery Systems; co-founder Keystone Nano
Narendra Vaish, PhD
Scientific Advisor
Expert in RNA Inhibition and siRNA drug design with >100 biomed patent applications
Sundeep Dugar, PhD Scientific Advisor >30 years in drug development (Scios, J&J, BMS, Schering-
Plough, Sphaera Pharma, Epirium Bio)
Lokesh Sikaria Board Member Founder and Managing Director at Moneta Ventures Kevin Nagle Board Member Investor, co-Founder of EnvisionRx Options, former Upjohn executive, co-Owner of Sacramento Kings (NBA) and Sac Republic FC (MLS)
Sabya Das Board Member Partner at Moneta Ventures